Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 412 participants.

Also called NCT03194945

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 412 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03194945
Other papers using this trial's data
  • Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial BMJ (Clinical research ed.), 2024-10-15 DOI, PubMed 39406449, PMC11474422 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03194945. Randomized; no masking; primary purpose treatment. Start 2017-11-01 (actual); primary completion 2022-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
CSII followed by Lina+MET
Intervention (Drug)
CSII followed by Lina
Intervention (Drug)
CSII followed by MET
Intervention (Drug)
CSII alone
Lead sponsor
Sun Yat-sen University (class: other)
Collaborator
The Seventh Affiliated Hospital of Sun Yat-sen University (class: other)
Collaborator
Guangdong Provincial Hospital of Traditional Chinese Medicine (class: other)
Collaborator
Guangdong Provincial People's Hospital (class: other)
Collaborator
The First Affiliated Hospital with Nanjing Medical University (class: other)
Collaborator
Dongguan People's Hospital (class: other government)
Collaborator
Clifford Hospital (class: not stated)
Collaborator
Guangzhou Panyu Central Hospital (class: other)
Collaborator
Nanfang Hospital, Southern Medical University (class: other)
Collaborator
Chinese PLA General Hospital (class: other)
Collaborator
Peking University People's Hospital (class: other)
Collaborator
Shanghai 10th People's Hospital (class: other)
Collaborator
Shanghai Changzheng Hospital (class: other)
Collaborator
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (class: other)
Collaborator
Huizhou Municipal Central Hospital (class: other)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 12

Record details

Record id
cardio:ct-nct03194945
Content hash
4cf4482c8dfa13e7091136f76ca246f6ffd76e28d56be18a396ac76aed1696a9